TY - JOUR
T1 - Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018
T2 - a systematic review and modelling study
AU - Wang, Xin
AU - Li, You
AU - O'Brien, Katherine L.
AU - Madhi, Shabir A.
AU - Widdowson, Marc Alain
AU - Byass, Peter
AU - Omer, Saad B.
AU - Abbas, Qalab
AU - Ali, Asad
AU - Amu, Alberta
AU - Azziz-Baumgartner, Eduardo
AU - Bassat, Quique
AU - Abdullah Brooks, W.
AU - Chaves, Sandra S.
AU - Chung, Alexandria
AU - Cohen, Cheryl
AU - Echavarria, Marcela
AU - Fasce, Rodrigo A.
AU - Gentile, Angela
AU - Gordon, Aubree
AU - Groome, Michelle
AU - Heikkinen, Terho
AU - Hirve, Siddhivinayak
AU - Jara, Jorge H.
AU - Katz, Mark A.
AU - Khuri-Bulos, Najwa
AU - Krishnan, Anand
AU - de Leon, Oscar
AU - Lucero, Marilla G.
AU - McCracken, John P.
AU - Mira-Iglesias, Ainara
AU - Moïsi, Jennifer C.
AU - Munywoki, Patrick K.
AU - Ourohiré, Millogo
AU - Polack, Fernando P.
AU - Rahi, Manveer
AU - Rasmussen, Zeba A.
AU - Rath, Barbara A.
AU - Saha, Samir K.
AU - Simões, Eric AF
AU - Sotomayor, Viviana
AU - Thamthitiwat, Somsak
AU - Treurnicht, Florette K.
AU - Wamukoya, Marylene
AU - Yoshida, Lay Myint
AU - Zar, Heather J.
AU - Campbell, Harry
AU - Nair, Harish
N1 - Funding Information:
This study was funded by WHO and the Bill & Melinda Gates Foundation (OPP 1172551). HN and HC are members of the Respiratory Syncytial Virus Consortium in Europe, which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (116019) that receives support from the EU Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations. The community-based paediatric acute respiratory infection study (primary investigator: L-MY) in central Vietnam was supported by the Japan Initiate for Global Research Network on infectious Diseases from the Ministry of Education, Culture, Sport, Science & Technology in Japan, and Japan Agency for Medical Research and Development (JP18fm0108001). The data collection at the Guatemalan sites was supported by Cooperative Agreement Numbers U01-GH0000028 and U01-GH001003 funded by the US Centers for Disease Control and Prevention (CDC). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the US CDC or the Department of Health and Human Services. XW and YL are supported by scholarships from China Scholarship Council. We thank Mark C Steinhoff, who led the maternal influenza immunisation trial in Nepal, for providing the influenza burden data among young infants. Dr Steinhoff sadly passed away when this manuscript was being drafted for publication. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.
Publisher Copyright:
© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2020/4
Y1 - 2020/4
N2 - Background: Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018. Methods: We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries. Findings: In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1–190·6), 10·1 million influenza-virus-associated ALRI cases (6·8–15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000–1 415 000), 15 300 in-hospital deaths (5800–43 800), and up to 34 800 (13 200–97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries. Interpretation: A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries. Funding: WHO; Bill & Melinda Gates Foundation.
AB - Background: Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018. Methods: We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries. Findings: In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1–190·6), 10·1 million influenza-virus-associated ALRI cases (6·8–15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000–1 415 000), 15 300 in-hospital deaths (5800–43 800), and up to 34 800 (13 200–97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries. Interpretation: A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries. Funding: WHO; Bill & Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=85079872948&partnerID=8YFLogxK
U2 - 10.1016/S2214-109X(19)30545-5
DO - 10.1016/S2214-109X(19)30545-5
M3 - Article
C2 - 32087815
AN - SCOPUS:85079872948
SN - 2214-109X
VL - 8
SP - e497-e510
JO - The Lancet Global Health
JF - The Lancet Global Health
IS - 4
ER -